Psoriasis

Smoking may be a risk factor for psoriasis

Smoking may be a risk factor for psoriasis

By

Researchers observed a positive correlation between the amount and duration of smoking and the occurrence of psoriasis.

Biosimilar ABP 501 and adalimumab safe and effective for plaque psoriasis

Biosimilar ABP 501 and adalimumab safe and effective for plaque psoriasis

Biosimilar ABP 501 has similar clinical efficacy and safety to adalimumab for the treatment of plaque psoriasis.

Dalazatide effective for skin lesions in plaque psoriasis

Dalazatide effective for skin lesions in plaque psoriasis

By

Dalazatide treatment reduced the plasma levels of multiple inflammation markers and reduced the expression of T cell activation markers on peripheral blood memory T cells.

Screening guidelines for pediatric psoriasis comorbidities

Screening guidelines for pediatric psoriasis comorbidities

By

The guidelines are the first to provide recommendations for comorbidity screening in pediatric psoriasis patients.

Cardiometabolic comorbidity rates high in psoriasis patients

Cardiometabolic comorbidity rates high in psoriasis patients

By

The most common comorbidities found in patients with psoriasis are hyperlipidemia, hypertension, depression, type 2 diabetes mellitus, and obesity.

Biologic treatment for psoriasis shows long-term effectiveness

Biologic treatment for psoriasis shows long-term effectiveness

By

Researchers sought to analyze long-term and real-world outcome data in patients with moderate-to-severe psoriasis after starting biologic treatment.

First-line biologic treatment for psoriasis influenced by specific factors

First-line biologic treatment for psoriasis influenced by specific factors

Presence of psoriatic arthritis, weight, employment status, baseline disease severity affect the selection of first-line biologic treatment.

High fatigue common in psoriatic arthritis

High fatigue common in psoriatic arthritis

Nearly 50% of patients with psoriatic arthritis report elevated levels of fatigue.

FDA approves Inflectra biosimilar for rheumatoid arthritis, psoriasis

FDA approves Inflectra biosimilar for rheumatoid arthritis, psoriasis

By

The biosimilar has also been approved for Crohn's disease, ulcerative colitis, and ankylosing spondylitis.

Psoriasis severity linked to work productivity, quality of life

Psoriasis severity linked to work productivity, quality of life

By

Mild, moderate, and severe psoriasis can patients' quality of life and workplace productivity.

Patients with psoriasis have an increased risk of abdominal aortic aneurysm

Patients with psoriasis have an increased risk of abdominal aortic aneurysm

Patients with psoriasis are more likely to have an abdominal aortic aneurysm, with the likelihood increasing with more severe psoriasis.

Severe psoriasis, nail pitting possible risks for development of psoriatic arthritis

Severe psoriasis, nail pitting possible risks for development of psoriatic arthritis

Researchers found that the annual incidence rate of PsA was 2.7 cases per 100 psoriasis patients.

Current and emerging medications for psoriasis

Current and emerging medications for psoriasis

A number of therapeutic options exist for patients with psoriasis, including phototherapy and systemic and biologic agents.

Brand-name, generic dermatologic drug prices increasing

Brand-name, generic dermatologic drug prices increasing

Escalating prices were found across all categories of dermatologic drugs, including anti-infective medications and treatments for psoriasis and rosacea.

Economic and racial barriers impact psoriasis treatment

Economic and racial barriers impact psoriasis treatment

Only 10% of Medicare beneficiaries were receiving biologic treatments for psoriasis.

El Niño linked to rise in a range of dermatologic conditions

El Niño linked to rise in a range of dermatologic conditions

El Nino and La Nina have been linked to increases in actinic keratosis, rosacea, dermatitis, psoriasis, and varicella, among other dermatologic conditions.

Bariatric surgery may reduce severity of psoriasis, psoriatic arthritis

Bariatric surgery may reduce severity of psoriasis, psoriatic arthritis

By

Patients with psoriasis or psoriatic arthritis who undergo bariatric surgery may see significant improvements in disease severity.

Biologic agents associated with high risk of hepatitis B virus flares in patients with psoriasis or rheumatoid arthritis

Biologic agents associated with high risk of hepatitis B virus flares in patients with psoriasis or rheumatoid arthritis

The use of biologic agents in treatment of patients rheumatoid arthritis or psoriasis is associated with a significant risk of heptatis B flares.

Combination use of methotrexate and golimumab may significantly improve psoriatic arthritis symptoms

Combination use of methotrexate and golimumab may significantly improve psoriatic arthritis symptoms

Using methotrexate and golimumab in combination may significantly improve some symptoms among patients diagnoes with psoriatic arthritis.

Golimumab reduces symptom severity, improves disease outcome in psoriatic arthritis

Golimumab reduces symptom severity, improves disease outcome in psoriatic arthritis

Several controlled clinical trials have proven the efficacy of golimumab in reducing symptom severity and improving disease outcomes in patients with psoriatic arthritis.

Public misconceptions about psoriasis contribute to its stigma

Public misconceptions about psoriasis contribute to its stigma

Many people think that psoriasis is contagious or that it is caused by an infection, which contribute to the stigma.

More severe psoriasis increases vascular inflammation levels

More severe psoriasis increases vascular inflammation levels

The most severe cases of psoriasis can increase vascular inflammation levels by as much as 41%.

More evidence shows association between psoriasis, depression

More evidence shows association between psoriasis, depression

Another study linked psoriasis to major depression, but the results still do not show a causal effect.

Brodalumab, secukinumab show efficacy for psoriasis treatment

Brodalumab, secukinumab show efficacy for psoriasis treatment

Two studies indicate that brodalumab and secukinumab had significant benefits for patients with psoriasis or psoriatic arthritis.

Increased risk for arrhythmia in psoriasis patients

Increased risk for arrhythmia in psoriasis patients

Patients with psoriasis, especially those with psoriatic arthritis, have an increased risk of arrhythmia.

Adding kunzea oil does not increase psoriasis treatment efficacy

Adding kunzea oil does not increase psoriasis treatment efficacy

Adding kunzea oil to topical psoriasis treatments did not improve their efficacy.

Biologics increase patient satisfaction in psoriasis treatment

Biologics increase patient satisfaction in psoriasis treatment

Patients with psoriasis who take biologic medications report more overall treatment satisfaction.

Biologic medications most effective for pediatric psoriasis

Biologic medications most effective for pediatric psoriasis

The safety and efficacy of 56 treatment courses for pediatric psoriasis were evaluated.

Psoriasis increases depression risk in women

Psoriasis increases depression risk in women

Women with psoriasis and psoriatic arthritis have an increased risk of depression.

Psoriasis drug may help preserve pancreatic function in type 1 diabetes

Psoriasis drug may help preserve pancreatic function in type 1 diabetes

Alefacept, a psoriasis treatment, can help preserve pancreas function in type 1 diabetes.

Sign Up for Free e-newsletters